The largest database of trusted experimental protocols

Lentiviral vectors small hairpin rna shrna

Manufactured by Genechem

Lentiviral vectors (LV)-small hairpin RNA (shRNA) are a type of gene delivery tool used for stable gene knockdown or silencing in various cell lines. They contain a shRNA expression cassette that can be integrated into the host cell's genome, leading to the production of shRNA and subsequent downregulation of target gene expression.

Automatically generated - may contain errors

2 protocols using lentiviral vectors small hairpin rna shrna

1

METTL3 Knockdown Using Lentiviral shRNA

Check if the same lab product or an alternative is used in the 5 most similar protocols
The lentiviral vectors (LV)-small hairpin RNA (shRNA) based on a third generation lentiviral system targeting METTL3 (LV-shMETTL3) and negative control (LV-shNC) were purchased from Shanghai GeneChem Co., Ltd. Briefly, 2.0 µg shRNA vector and 2.0 µg packaging mix plasmids were transfected into 293T cells (cat. no. C6008; Beyotime Institute of Biotechnology) using Lipofectamine 3000® reagent (Thermo Fisher Scientific, Inc.) for 24 h at 37°C, and the medium was then harvested and the virus was extracted by 85,000 × g ultracentrifugation at 4°C for 2 h in a centrifuge (Beckman Coulter, Inc.). For lentiviral transduction, the cells were seeded in six-well plates at a density of 50,000 cells/well. The lentiviral vector was added at a multiplicity of infection of 20, with 8 µg polybrene (Sigma-Aldrich; Merck KGaA) per well. After 72 h, the cells infected with the lentiviral vectors were selected using puromycin (Beyotime Institute of Biotechnology). The concentration of puromycin used for selection was 2 µg/ml, and the concentration used for maintenance was 1 µg/ml. The knockdown efficiency was evaluated using RT-qPCR.
+ Open protocol
+ Expand
2

Lentiviral shRNA Knockdown Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
The lentiviral vectors (Lv)-small hairpin RNA (shRNA) based on a 3rd generation lentiviral system targeting PLAU (Lv-shSPP1), Lv-shYY1, and negative control (Lv-shCon) were purchased from Shanghai GeneChem Co., Ltd. Briefly, 1.5 µg shRNA vector and 1.5 µg package mix plasmids were transfected into 293T cells (cat. no. C6008; Beyotime Institute of Biotechnology) with Lipofectamine 3000® reagent (cat. no. L3000001; Thermo Fisher Scientific, Inc.) for 24 h at 37°C, and the medium was then harvested and the virus was extracted by 80,000 × g-ultracentrifugation at 4°C for 2 h in a centrifuge (Beckman Coulter, Inc.). For lentiviral transduction, the cells were seeded in six-well plates at a density of 50,000 cells/well. The lentiviral vector was added at a multiplicity of infection of 15, with 5 µl polybrene (Sigma-Aldrich; Merck KGaA) per well. After 72 h, cells infected with the lentiviral vectors were selected using 1 µg/ml puromycin (Beyotime Institute of Biotechnology). Knockdown efficiency was evaluated using RT-qPCR.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!